Loading...
Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer
PURPOSE: The independent predictive information from progesterone receptor (PgR) positivity for breast cancer treated with tamoxifen has been questioned after an overview by the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). However, the studies in the overview were to a large content...
Saved in:
| Published in: | Breast Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer US
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5065613/ https://ncbi.nlm.nih.gov/pubmed/27722840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-4007-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|